Zenith Health — 360° view

Zenith Health, a company in the Pharmaceuticals industry, reported revenue of ₹2.01 crore and net profit of ₹0.02 crore for the September 2026 quarter.

Zenith Health (BSE: ZENITHHE) closed at ₹3.17 on 20 Nov 2026, down 17.7% over the past year. Its market capitalisation is ₹17 crore and it trades at 425.8 times earnings.

Share price
₹3.17 (20 Nov 2026)
Market cap
₹17 Cr (20 Nov 2026)
P/E
425.79 (20 Nov 2026)
Revenue
₹2 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
0.27% (FY26)
ROE
0.13% (FY26)
Book value
₹1.41 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹4.15 / ₹2.23 (20 Nov 2026)
1-year return
-17.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: ZENITHHE

Incorporated in 1993, Zenith Health care Ltd is engaged in manufacturing and trading of pharma products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.